UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 25, 2021 (
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| |
||||
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company.
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02 | Results of Operations and Financial Condition. |
On February 25, 2021, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter and year ended December 31, 2020. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
The Compensation Committee of the Board of Directors of the Company authorized the Company to grant the following awards of restricted shares of the Company’s Common Stock to the following executive officers of the Company, which were in addition to awards made under previously disclosed compensation plans, effective February 24, 2021 (the “Grant Date”):
| Executive Officer |
Restricted Shares of Common Stock |
|||
| Brad Bickham |
8,244 | |||
| Brian Poff |
8,244 | |||
These restricted shares will vest 60% on the third anniversary of the Grant Date and 40% on the fourth anniversary of the Grant Date, subject to customary provisions for continued service and acceleration on a change in control.
| Item 7.01. | Regulation FD Disclosure |
On February 25, 2021, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter and year ended December 31, 2020, the text of which is set forth as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits:
| Exhibit |
Description | |
| 99.1 | Press Release of Addus HomeCare Corporation dated February 25, 2021. | |
| 104 | Cover Page Interactive Data File (embedded within Inline XBRL document). | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADDUS HOMECARE CORPORATION | ||||||
| Date: February 25, 2021 | By: | /s/ Brian Poff | ||||
| Brian Poff | ||||||
| Chief Financial Officer | ||||||
Exhibit 99.1
| Contacts: | ||||
| Brian W. Poff | Dru Anderson | |||
| Executive Vice President, Chief Financial Officer | Corporate Communications, Inc. | |||
| Addus HomeCare Corporation | (615) 324-7346 | |||
| (469) 535-8200 | dru.anderson@cci-ir.com | |||
| investorrelations@addus.com |
ADDUS HOMECARE ANNOUNCES FOURTH-QUARTER FINANCIAL RESULTS
Revenues of $196.0 Million
Net Income of $8.4 Million, or $0.53 per Diluted Share
Adjusted Earnings per Diluted Share up 12.3% to $0.82
Adjusted EBITDA Increases 11.6% to $20.9 Million
Frisco, Texas (February 25, 2021) – Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2020.
Net service revenues increased 1.9% for the fourth quarter to $196.0 million from $192.4 million for the fourth quarter of 2019. Net income was $8.4 million for the fourth quarter of 2020, compared with $10.7 million for the fourth quarter last year, while net income per diluted share was $0.53 compared with $0.68 for the same period a year ago. Adjusted EBITDA increased 11.6% to $20.9 million for the fourth quarter of 2020 from $18.8 million for the fourth quarter of 2019. Adjusted net income per diluted share was $0.82 for the fourth quarter of 2020 compared with $0.73 for the fourth quarter of 2019. (See page 8 for a reconciliation of all non-GAAP and GAAP financial measures in this news release.)
Adjusted net income per diluted share for the fourth quarter of 2020 excludes COVID-19 expenses of $0.01, M&A expenses of $0.15, restructure and other non-recurring costs of $0.03, and stock-based compensation expense of $0.10. Adjusted net income per diluted share for the fourth quarter of 2019 excluded the favorable impact of the retroactive Illinois rate increase of $0.12, M&A expenses of $0.08, restructure and other non-recurring costs of $0.01 and stock-based compensation expense of $0.08.
For 2020, net service revenues increased 17.9% to $764.8 million from $648.8 million for 2019. Net income from continuing operations increased 28.4% to $33.1 million for 2020 compared with $25.8 million for the prior year, while net income from continuing operations per diluted share increased to $2.08 from $1.81. Adjusted EBITDA was $76.9 million for 2020, an increase of 31.0% compared with $58.7 million for 2019. Adjusted net income from continuing operations per diluted share grew 23.2% to $3.08 for 2020 from $2.50 for 2019.
Adjusted net income per diluted share for the full year 2020 excludes loss on sale of assets of $0.01, COVID-19 expenses of $0.07, M&A expenses of $0.34, restructure and other non-recurring costs of $0.28, and stock-based compensation expense of $0.30. Adjusted net income per diluted share for the full year 2019 excluded interest income from Illinois of $0.03, M&A expenses of $0.26, restructure and other non-recurring costs of $0.14, and stock-based compensation expense of $0.32.
Commenting on the results, Dirk Allison, President and Chief Executive Officer, said, “We are pleased to report solid financial and operating results for the fourth quarter and 2020, capping off another year of impressive growth and progress for Addus. These results were achieved despite some extraordinary challenges, including the substantial surge of COVID-19 cases during November and December. We commend the heroic work and dedication of our team of frontline caregivers and support staff who continue our mission to provide essential home care services and serve the needs of patients who count on Addus for safe and cost-effective care. As conditions surrounding the pandemic begin to improve and vaccinations become more widely distributed across the country, we are confident that Addus is well positioned to meet expected demand in a less restrictive and more favorable environment.”
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 2
February 25, 2021
At December 31, 2020, the Company had cash of $145.1 million and bank debt of $196.6 million, with availability under its revolving credit facility of $112.6 million. Net cash provided by operating activities was $36.1 million for the fourth quarter of 2020 and $109.4 million for 2020, the highest annual level in Addus history.
Mr. Allison added, “In addition to organic growth, we continued to pursue strategic acquisition opportunities in 2020. Despite the pandemic, we were able to complete four acquisitions for the year with a total of approximately $84 million in annualized revenue. The integration process has gone well for these transactions, and we are excited to have these new providers and caregivers join the Addus family. We intend to continue pursuing aggressive acquisition objectives in 2021 with a strong pipeline in each of our personal care, hospice, and home health segments. Our capital structure supports this important aspect of our growth strategy and allows us to take advantage of future acquisition opportunities as they occur.
“Looking ahead to 2021, we are confident that we are well-positioned to achieve further profitable growth both organically and from acquisitions. We remain focused on our mission to provide home care services that allow individuals to remain in the safety and comfort of their preferred home setting. We are proud of our ability to execute our strategy this past year, and we believe we have an exceptional team in place that provides a stable foundation for continued success as a leading provider of home care services. Addus offers a strong value proposition, and we look forward to extending our market reach while continuing to deliver value to our shareholders,” Mr. Allison concluded.
Non-GAAP Financial Measures
The information provided in this release includes adjusted net income per diluted share, adjusted EBITDA, and adjusted net service revenues, which are non-GAAP financial measures. The Company defines adjusted net income as net income before the net-of-tax amounts of interest income from the State of Illinois, COVID-19 adjustments for temporary rate increases and expenses, M&A expenses, stock-based compensation expense, restructure charges, severance and other costs and loss on the sale of assets associated with Hospice Partners of Kansas. The Company defines adjusted EBITDA as net income before interest expense, interest income, other non-operating income, COVID-19 adjustments for temporary rate increases and expenses, taxes, depreciation, amortization, interest income from the State of Illinois, M&A expenses, stock-based compensation expense, restructure charges, severance and other costs and loss on the sale of assets associated with Hospice Partners of Kansas. The Company defines adjusted diluted earnings per share as earnings per share adjusted for interest income from the State of Illinois, COVID-19 expenses, M&A expenses, stock compensation expense and restructure expense, severance and other costs and loss on the sale of assets associated with Hospice Partners of Kansas. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income and a reconciliation of adjusted diluted earnings per share to earnings per share, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA and adjusted diluted earnings per share are useful to investors, management, and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers. With respect to COVID-19 expenses, the Company views these expenses as unrelated to the Company’s long-term performance since they are directly related to the sudden onset COVID-19 pandemic. With respect to COVID-19 temporary rate increases, the Company similarly views these as unrelated to the Company’s long-term performance and has adjusted for those increases, net of the amount required to be passed through to caregivers as a condition of the increase.
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 3
February 25, 2021
Conference Call
Addus will host a conference call on Friday, February 26, 2021, beginning at 9:00 a.m. Eastern time. The toll-free dial-in number is (877) 930-8289 (international dial-in number is (253) 336-8714), pass code 9398711. A telephonic replay of the conference call will be available through midnight March 5, 2021, by dialing (855) 859-2056 (international dial-in number is (404)-537-3406) and entering pass code 9398711. A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.
Forward-Looking Statements
Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, the anticipated impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, caused by a novel strain of the coronavirus (COVID-19), and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on August 10, 2020, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).
About Addus HomeCare
Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 44,000 consumers through 212 locations across 22 states. For more information, please visit www.addus.com.
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 4
February 25, 2021
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(amounts and shares in thousands, except per share data)
(Unaudited)
| Income Statement Information: | For the Three Months Ended December 31, |
For the Twelve Months Ended December 31, |
||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Net service revenues |
$ | 195,996 | $ | 192,376 | $ | 764,775 | $ | 648,791 | ||||||||
| Cost of service revenues |
136,892 | 134,834 | 538,538 | 469,553 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Gross profit |
59,104 | 57,542 | 226,237 | 179,238 | ||||||||||||
| 30.2 | % | 29.9 | % | 29.6 | % | 27.6 | % | |||||||||
| General and administrative expenses |
44,209 | 39,803 | 169,679 | 133,912 | ||||||||||||
| Depreciation and amortization |
3,179 | 3,209 | 12,051 | 10,574 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total operating expenses |
47,388 | 43,012 | 181,730 | 144,486 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating income from continuing operations |
11,716 | 14,530 | 44,507 | 34,752 | ||||||||||||
| Total interest expense, net |
832 | 514 | 2,565 | 1,582 | ||||||||||||
| Income before income taxes |
10,884 | 14,016 | 41,942 | 33,170 | ||||||||||||
| Income tax expense |
2,435 | 3,279 | 8,809 | 7,359 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income from continuing operations |
8,449 | 10,737 | 33,133 | 25,811 | ||||||||||||
| Discontinued operations: |
||||||||||||||||
| Loss from Home Health Business, net of tax |
— | — | — | (574 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Earnings from discontinued operations |
— | — | — | (574 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 8,449 | $ | 10,737 | $ | 33,133 | $ | 25,237 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income (loss) per diluted share: |
||||||||||||||||
| Continuing Operations |
$ | 0.53 | $ | 0.68 | $ | 2.08 | $ | 1.81 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Discontinued Operations |
$ | — | $ | — | $ | — | $ | (0.04 | ) | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Weighted average number of common shares outstanding: |
||||||||||||||||
| Diluted |
16,013 | 15,881 | 15,956 | 14,248 | ||||||||||||
| Cash Flow Information: | For the Three Months Ended December 31, |
For the Twelve Months Ended December, |
||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Net cash provided by operating activities |
$ | 36,112 | $ | 3,935 | $ | 109,411 | $ | 12,019 | ||||||||
| Net cash (used in) investing activities |
(196,729 | ) | (132,396 | ) | (214,236 | ) | (188,697 | ) | ||||||||
| Net cash provided by financing activities |
135,364 | 566 | 138,189 | 217,986 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net change in cash |
(25,253 | ) | (127,895 | ) | 33,364 | 41,308 | ||||||||||
| Cash at the beginning of the period |
170,331 | 239,609 | 111,714 | 70,406 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Cash at the end of the period |
$ | 145,078 | $ | 111,714 | $ | 145,078 | $ | 111,714 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 5
February 25, 2021
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Amounts in thousands)
(Unaudited)
| December 31, | ||||||||
| 2020 | 2019 | |||||||
| Assets |
||||||||
| Current assets |
||||||||
| Cash |
$ | 145,078 | $ | 111,714 | ||||
| Accounts receivable, net |
132,650 | 149,680 | ||||||
| Prepaid expenses and other current assets |
9,969 | 7,993 | ||||||
|
|
|
|
|
|||||
| Total current assets |
287,697 | 269,387 | ||||||
|
|
|
|
|
|||||
| Property and equipment, net |
19,749 | 12,156 | ||||||
|
|
|
|
|
|||||
| Other assets |
||||||||
| Goodwill |
469,072 | 275,368 | ||||||
| Intangible assets, net |
71,549 | 57,079 | ||||||
| Deferred tax assets, net |
6,524 | 1,647 | ||||||
| Operating lease assets |
37,991 | 21,111 | ||||||
|
|
|
|
|
|||||
| Total other assets |
585,136 | 355,205 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 892,582 | $ | 636,748 | ||||
|
|
|
|
|
|||||
| Liabilities and stockholders’ equity |
||||||||
| Current liabilities |
||||||||
| Accounts payable |
$ | 23,705 | $ | 19,641 | ||||
| Accrued payroll |
35,815 | 30,587 | ||||||
| Accrued expenses |
37,564 | 22,429 | ||||||
| Government stimulus advances |
32,087 | — | ||||||
| Accrued workers compensation |
13,759 | 14,143 | ||||||
| Current portion of long-term debt, net of debt issuance costs |
971 | 728 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
143,901 | 87,528 | ||||||
| Long-term debt, less current portion, net of debt issuance costs |
193,901 | 59,164 | ||||||
| Long-term lease liability, less current portion |
35,516 | 14,301 | ||||||
| Other long-term liabilities |
588 | 163 | ||||||
|
|
|
|
|
|||||
| Total long-term liabilities |
230,005 | 73,628 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
373,906 | 161,156 | ||||||
|
|
|
|
|
|||||
| Total stockholders’ equity |
518,676 | 475,592 | ||||||
|
|
|
|
|
|||||
| Total liabilities and stockholders’ equity |
$ | 892,582 | $ | 636,748 | ||||
|
|
|
|
|
|||||
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 6
February 25, 2021
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Net Service Revenues by Segment
(Amounts in thousands)
(Unaudited)
| For the Three Months Ended December 31, |
For the Twelve Months Ended December 31, |
|||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Personal Care |
$ | 164,384 | $ | 161,604 | $ | 647,233 | $ | 580,728 | ||||||||
| Hospice |
27,574 | 26,373 | 101,297 | 53,601 | ||||||||||||
| Home Health |
4,038 | 4,399 | 16,245 | 14,462 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total Revenue |
$ | 195,996 | $ | 192,376 | $ | 764,775 | $ | 648,791 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 7
February 25, 2021
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Key Statistical and Financial Data (Unaudited)
| For the Three Months Ended December 31, |
For the Twelve Months Ended December 31, |
|||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| General |
||||||||||||||||
| Personal Care |
||||||||||||||||
| States served at period end |
— | — | 22 | 24 | ||||||||||||
| Locations at period end |
— | — | 170 | 152 | ||||||||||||
| Average billable census - same store |
37,665 | 39,179 | 37,641 | 37,892 | ||||||||||||
| Average billable census - acquisitions (1) |
1,538 | — | 1,558 | 1,296 | ||||||||||||
| Average billable census total |
39,203 | 39,179 | 39,199 | 39,188 | ||||||||||||
| Billable hours (in thousands) |
7,820 | 7,814 | 30,645 | 29,732 | ||||||||||||
| Average billable hours per census per month |
66.0 | 66.0 | 64.7 | 62.7 | ||||||||||||
| Billable hours per business day |
118,490 | 118,393 | 116,967 | 113,915 | ||||||||||||
| Revenues per billable hour |
$ | 20.98 | $ | 20.10 | $ | 21.07 | $ | 19.50 | ||||||||
| Organic growth |
||||||||||||||||
| - Revenue |
2.6 | % | 13.6 | % | 5.9 | % | 8.2 | % | ||||||||
| Hospice |
||||||||||||||||
| Locations served at period end |
— | — | 34 | 35 | ||||||||||||
| Admissions |
1,983 | 1,547 | 6,376 | 3,095 | ||||||||||||
| Average daily census |
2,492 | 1,841 | 2,619 | 1,783 | ||||||||||||
| Average length of stay |
108.3 | 92.6 | 104.9 | 106.8 | ||||||||||||
| Patient days |
174,407 | 170,336 | 657,172 | 349,866 | ||||||||||||
| Revenue per patient day |
$ | 158.10 | $ | 154.83 | $ | 154.14 | $ | 153.20 | ||||||||
| Organic growth |
||||||||||||||||
| - Revenue |
(10.6 | )% | 20.4 | % | (5.3 | )% | — | % | ||||||||
| - Average daily census |
(13.5 | )% | 22.7 | % | 1.2 | % | — | % | ||||||||
| Home Health |
||||||||||||||||
| Locations served at period end |
— | — | 10 | 11 | ||||||||||||
| New Admissions |
1,088 | 1,022 | 4,122 | 3,347 | ||||||||||||
| Recertifications |
572 | 709 | 2,578 | 2,658 | ||||||||||||
| Total Volume |
1,660 | 1,731 | 6,700 | 6,005 | ||||||||||||
| Visits |
26,890 | 33,675 | 118,470 | 108,863 | ||||||||||||
| Organic growth |
||||||||||||||||
| - Revenue |
(8.2 | )% | 12.3 | % | (3.0 | )% | — | % | ||||||||
| - Total volume |
(4.1 | )% | 7.0 | % | 9.1 | % | — | % | ||||||||
| Percentage of Revenues by Payor: |
||||||||||||||||
| Personal Care |
||||||||||||||||
| State, local and other governmental programs |
49.8 | % | 50.8 | % | 50.2 | % | 52.2 | % | ||||||||
| Managed care organizations |
45.0 | 43.0 | 44.3 | 41.3 | ||||||||||||
| Private duty |
3.0 | 3.6 | 3.2 | 3.7 | ||||||||||||
| Commercial |
1.5 | 1.6 | 1.5 | 1.6 | ||||||||||||
| Other |
0.7 | % | 1.0 | % | 0.8 | % | 1.2 | % | ||||||||
| Hospice |
||||||||||||||||
| Medicare |
93.2 | % | 92.6 | % | 92.9 | % | 92.6 | % | ||||||||
| Managed care organizations |
4.4 | 5.1 | 4.9 | 5.2 | ||||||||||||
| Other |
2.4 | % | 2.3 | % | 2.2 | % | 2.2 | % | ||||||||
| Home Health |
||||||||||||||||
| Medicare |
76.8 | % | 74.4 | % | 78.6 | % | 77.6 | % | ||||||||
| Managed care organizations |
21.3 | 24.3 | 19.6 | 20.3 | ||||||||||||
| Other |
1.9 | % | 1.3 | % | 1.8 | % | 2.1 | % | ||||||||
| (1) | The average billable census in acquisitions of 1,199 for the three months ended December 31, 2019, was reclassified to average billable census - same stores for comparability purposes. The average billable census for the three and twelve months ended December 31, 2020, was prorated for the date of the acquisition. |
-MORE-
ADUS Announces Fourth-Quarter and 2020 Financial Results
Page 8
February 25, 2021
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures
(Amounts in thousands, except per share data)
(Unaudited)
| For the Three Months Ended December 31, |
For the Twelve Months Ended December 31, |
|||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Reconciliation of Adjusted EBITDA to Net Income: (1) |
||||||||||||||||
| Net income |
$ | 8,449 | $ | 10,737 | $ | 33,133 | $ | 25,237 | ||||||||
| Less: Loss from discontinued operations, net of tax |
— | — | — | 574 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income from continuing operations |
8,449 | 10,737 | 33,133 | 25,811 | ||||||||||||
| Interest expense, net |
832 | 591 | 2,565 | 2,233 | ||||||||||||
| Interest income from Illinois |
— | (77 | ) | — | (651 | ) | ||||||||||
| Impact of retroactive Illinois rate increase |
— | (2,485 | ) | — | — | |||||||||||
| Loss on sale of assets |
13 | — | 294 | — | ||||||||||||
| Secondary offering costs |
— | — | — | 127 | ||||||||||||
| Income tax expense |
2,435 | 3,279 | 8,809 | 7,359 | ||||||||||||
| Depreciation and amortization |
3,179 | 3,209 | 12,051 | 10,574 | ||||||||||||
| COVID-19 expense, net |
252 | — | 1,480 | — | ||||||||||||
| M&A expenses |
3,074 | 1,593 | 6,956 | 4,775 | ||||||||||||
| Stock-based compensation expense |
2,017 | 1,581 | 6,005 | 5,766 | ||||||||||||
| Restructure and other non-recurring costs |
694 | 339 | 5,614 | 2,703 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted EBITDA |
$ | 20,945 | $ | 18,767 | $ | 76,907 | $ | 58,697 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Reconciliation of Adjusted Net Income to Net Income: (2) |
||||||||||||||||
| Net income |
$ | 8,449 | $ | 10,737 | $ | 33,133 | $ | 25,237 | ||||||||
| Loss from discontinued operations, net of tax |
— | — | — | 574 | ||||||||||||
| Interest income from Illinois, net of tax |
— | (59 | ) | — | (507 | ) | ||||||||||
| Impact of retroactive Illinois rate increase, net of tax |
— | (1,903 | ) | — | — | |||||||||||
| Loss on sale of assets, net of tax |
10 | — | 232 | — | ||||||||||||
| COVID-19 expense, net of tax |
196 | — | 1,169 | — | ||||||||||||
| M&A expenses, net of tax |
2,365 | 1,220 | 5,456 | 3,715 | ||||||||||||
| Stock-based compensation expense, net of tax |
1,551 | 1,210 | 4,728 | 4,489 | ||||||||||||
| Restructuring and other non-recurring costs, net of tax |
540 | 260 | 4,421 | 2,202 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted Net Income |
$ | 13,110 | $ | 11,465 | $ | 49,139 | $ | 35,710 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3) |
|
|||||||||||||||
| Net income per diluted share |
$ | 0.53 | $ | 0.68 | $ | 2.08 | $ | 1.81 | ||||||||
| Interest income from Illinois per diluted share |
— | — | — | (0.03 | ) | |||||||||||
| Impact of retroactive Illinois rate increase per diluted share |
— | (0.12 | ) | — | — | |||||||||||
| Loss on sale of assets per diluted share |
— | — | 0.01 | — | ||||||||||||
| COVID-19 expense per diluted share |
0.01 | — | 0.07 | — | ||||||||||||
| M&A expenses per diluted share |
0.15 | 0.08 | 0.34 | 0.26 | ||||||||||||
| Restructure and other non-recurring costs per diluted share |
0.03 | 0.01 | 0.28 | 0.14 | ||||||||||||
| Stock-based compensation expense per diluted share |
0.10 | 0.08 | 0.30 | 0.32 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted net income per diluted share |
$ | 0.82 | $ | 0.73 | $ | 3.08 | $ | 2.50 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) | We define Adjusted EBITDA as earnings before interest expense, interest income from the state of Illinois, other non-operating income, taxes, depreciation, amortization, COVID expenses, M&A expenses, stock-based compensation expense, restructure expenses, other non-recurring costs and loss on the sale of assets associated with Hospice Partners of Kansas. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. |
| (2) | We define Adjusted Net Income as net income before interest income from the state of Illinois, COVID expenses, M&A expenses, stock-based compensation expense, restructure expenses, other non-recurring costs and loss on the sale of assets associated with Hospice Partners of Kansas. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. |
| (3) | We define Adjusted diluted earnings per share as earnings per share, adjusted for interest income from the State of Illinois, COVID expenses, M&A expenses, stock compensation expense and restructure expense, other non-recurring costs and loss on the sale of assets associated with Hospice Partners of Kansas. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. |
-END-